MolNFT v1 · #525382 · protein
AlphaFold monomer V2.0 prediction for endoribonuclease ybey (Q161G7)
Q161G7: “AlphaFold monomer V2.0 prediction for endoribonuclease ybey (Q161G7)”. 1 pocket (best druggability 0.29). MolNFT v1 #525382 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- Accession
- Q161G7
- Type
- protein
- Length
- 166 residues
- Chains
- 1
- Collection
- MolNFT v1 / AlphaFold
- Contract
- 0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
- Owner
- 0xBb6f434FB4BD201f364930eace54164F9Da0c1ce
- Molecule
- Endoribonuclease ybey
- UniProt
- Q161G7
- Pockets
- 1 · best druggability 0.29
Structure
1 distinct chain · 47% helix, 17% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Endoribonuclease ybey | protein | 166 | 47% helix, 17% strand | Q161G7 |
Pockets
1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 68 | 0.29 | 0.74 | 17 | empty |
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q161G7
- Elsewhere: UniProt Q161G7 · AlphaFold DB Q161G7
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.